Physician

Andrzej Jakubowiak

According to 2025 Medicare claims, Andrzej Jakubowiak (NPI: 1134205081) practices hematopoietic cell transplantation and cellular therapy in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is THE UNIVERSITY OF CHICAGO MEDICAL CENTER (NPI: 1033218128; TIN: 36-3488183) and primary practice location at 60637-1447. Jakubowiak is affiliated with the UCMCNACO, LLC (ACO ID: A3531), participating under the MSSP model.

Jakubowiak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 143 traditional Medicare patients, billed 517 HCPCS/CPT codes, and received $51,650 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 479 prescription claims across 63 beneficiaries totaling $6,395,391 in drug costs, led by Revlimid (Lenalidomide). Open Payments data shows 54 records totaling $1,037,149. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,052,974 and ending at $6,395,391. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	79	469	$41,121
2016	105	479	$44,315
2017	162	832	$95,920
2018	189	897	$107,581
2019	145	766	$93,269
2020	142	735	$82,850
2021	142	721	$86,553
2022	126	461	$48,634
2023	125	485	$52,143
2024	143	517	$51,650

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	298	$1,052,974
2016	45	249	$2,143,854
2017	103	663	$6,351,796
2018	112	680	$6,709,465
2019	102	533	$5,527,523
2020	70	457	$5,924,936
2021	65	544	$8,579,439
2022	56	437	$6,844,567
2023	49	354	$4,963,107
2024	63	479	$6,395,391

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	11	12	$129
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	100	212	$111
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	29	197	$94
99239	Hospital discharge day management, more than 30 minutes	14	15	$75
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	31	45	$73

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	139	3,780	$2,505,180
Pomalyst	Pomalidomide	89	2,492	$1,881,451
Lenalidomide	Lenalidomide	104	2,905	$1,425,690
Venclexta	Venetoclax	31	928	$488,775
Eliquis	Apixaban	18	765	$14,734

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$49,121	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	18	$988,028	Amgen Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrzej Jakubowiak?

Tedicare shows public-source Medicare data for Andrzej Jakubowiak (NPI 1134205081), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrzej Jakubowiak have ACO affiliation data?

Andrzej Jakubowiak is shown with ACO affiliation data for UCMCNACO, LLC (MSSP, ACO ID A3531).

What billing organization is linked to Andrzej Jakubowiak?

Andrzej Jakubowiak is linked to THE UNIVERSITY OF CHICAGO MEDICAL CENTER (billing NPI 1033218128) in the available physician profile data.

Does Andrzej Jakubowiak have Open Payments data?

Andrzej Jakubowiak has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.